What does Apotheek Vermylen do?

Apotheek Vermylen is a pharmacy in Heist-op-den-Berg. Private Limited, started on 18 August 1980, 1 establishment.

What is the address of Apotheek Vermylen?

The registered office of Apotheek Vermylen is located at Leo Kempenaersstraat 7, 2223 Heist-op-den-Berg.

Is Apotheek Vermylen still active?

Yes. According to the CBE (31 October 2026) Apotheek Vermylen is active, legal situation “Normale toestand”, started on 18 August 1980.

Is Apotheek Vermylen registered on Peppol?

Yes, Apotheek Vermylen is registered on the Peppol network with ID 0208:0420633867.

What is the enterprise number of Apotheek Vermylen?

The enterprise number of Apotheek Vermylen is BE0420633867.

When was Apotheek Vermylen founded?

Apotheek Vermylen was founded on 18 August 1980.

Who are the directors of Apotheek Vermylen?

According to the 2025 annual accounts, the directors of Apotheek Vermylen are: Kathleen Vermylen, Storms Pharma BVBA.

Is Apotheek Vermylen a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 18 August 1980; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Apotheek Vermylen make in 2025?

Apotheek Vermylen posted a profit after taxes of € 234,765 in financial year 2025.

What is the revenue of Apotheek Vermylen?

As a small company, Apotheek Vermylen is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 476,665.

How much does an employee at Apotheek Vermylen earn?

The average wage cost per full-time employee at Apotheek Vermylen was € 77,400 in 2025: staff costs of € 108,387 for 1.4 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Apotheek Vermylen have?

According to the 2025 annual accounts, Apotheek Vermylen has 1.4 full-time equivalents (FTE).

Apotheek Vermylen (Private Limited) - Heist-op-den-Berg

Dossier Apotheek Vermylen, printed on 31 October 2026 from databakkes.be/en/0420633867/apotheek-vermylen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Apotheek Vermylen from Heist-op-den-Berg, company number BE0420633867, closed financial year 2025 with a result of € 234,765 after tax. For that financial year Apotheek Vermylen recorded a gross margin of € 476,665 and equity of € 423,279. Compared with financial year 2024, the result moved from € 212,201 to € 234,765. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 3, 2026.

What it is worth Healthy

€ 423,279

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 234,765

▲ 11% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 262,757

▼ 4% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 234,765 paid out

100 % of the profit went to the shareholders, mostly to Storms Pharma (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

1.4

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 108,387

▲ 8% vs 2024

€ 77,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 2,849

▲ 232% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 77,952

▼ 19% vs 2024

€ 12,398 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 310,016

▲ 42% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 22,648

▼ 4% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 325,157 Gross margin 2022: € 325,157 First fiscal year in the series	€ 421,750 Gross margin 2023: € 421,750 ▲ 30% vs 2022 (€ 325,157) Favourable step	€ 433,580 Gross margin 2024: € 433,580 ▲ 3% vs 2023 (€ 421,750) Favourable step	€ 476,665 Gross margin 2025: € 476,665 ▲ 10% vs 2024 (€ 433,580) Favourable step	▲ 10%
Profit after taxes	€ 157,018 Profit after taxes 2022: € 157,018 First fiscal year in the series	€ 217,635 Profit after taxes 2023: € 217,635 ▲ 39% vs 2022 (€ 157,018) Favourable step	€ 212,201 Profit after taxes 2024: € 212,201 ▼ 2% vs 2023 (€ 217,635) Unfavourable step	€ 234,765 Profit after taxes 2025: € 234,765 ▲ 11% vs 2024 (€ 212,201) Favourable step	▲ 11%
Equity	€ 373,540 Equity 2022: € 373,540 First fiscal year in the series	€ 423,540 Equity 2023: € 423,540 ▲ 13% vs 2022 (€ 373,540) Favourable step	€ 423,279 Equity 2024: € 423,279 Unchanged (€ 423,540) Unfavourable step	€ 423,279 Equity 2025: € 423,279 Unchanged (€ 423,279) Unchanged
Total debts	€ 598,296 Total debts 2022: € 598,296 First fiscal year in the series	€ 369,176 Total debts 2023: € 369,176 ▼ 38% vs 2022 (€ 598,296) Favourable step	€ 462,153 Total debts 2024: € 462,153 ▲ 25% vs 2023 (€ 369,176) Unfavourable step	€ 646,495 Total debts 2025: € 646,495 ▲ 40% vs 2024 (€ 462,153) Unfavourable step	▲ 40%
Cash	€ 250,859 Cash 2022: € 250,859 First fiscal year in the series	€ 157,312 Cash 2023: € 157,312 ▼ 37% vs 2022 (€ 250,859) Unfavourable step	€ 274,421 Cash 2024: € 274,421 ▲ 74% vs 2023 (€ 157,312) Favourable step	€ 262,757 Cash 2025: € 262,757 ▼ 4% vs 2024 (€ 274,421) Unfavourable step	▼ 4%
Land & buildings	€ 82,745 Land & buildings 2022: € 82,745 First fiscal year in the series	€ 76,573 Land & buildings 2023: € 76,573 ▼ 7% vs 2022 (€ 82,745) Unchanged	€ 78,168 Land & buildings 2024: € 78,168 ▲ 2% vs 2023 (€ 76,573) Unchanged	€ 71,178 Land & buildings 2025: € 71,178 ▼ 9% vs 2024 (€ 78,168) Unchanged	▼ 9%
Retained profit	€ 71,882 Retained profit 2022: € 71,882 First fiscal year in the series	€ 121,882 Retained profit 2023: € 121,882 ▲ 70% vs 2022 (€ 71,882) Favourable step	€ 121,622 Retained profit 2024: € 121,622 Unchanged (€ 121,882) Unfavourable step	€ 121,622 Retained profit 2025: € 121,622 Unchanged (€ 121,622) Unchanged
Dividend	€ 157,018 Dividend 2022: € 157,018 First fiscal year in the series	€ 167,635 Dividend 2023: € 167,635 ▲ 7% vs 2022 (€ 157,018) Unchanged	€ 212,461 Dividend 2024: € 212,461 ▲ 27% vs 2023 (€ 167,635) Unchanged	€ 234,765 Dividend 2025: € 234,765 ▲ 10% vs 2024 (€ 212,461) Unchanged	▲ 10%
Bank debt	€ 149,048 Bank debt 2022: € 149,048 First fiscal year in the series	€ 123,050 Bank debt 2023: € 123,050 ▼ 17% vs 2022 (€ 149,048) Favourable step	€ 96,767 Bank debt 2024: € 96,767 ▼ 21% vs 2023 (€ 123,050) Favourable step	€ 77,952 Bank debt 2025: € 77,952 ▼ 19% vs 2024 (€ 96,767) Favourable step	▼ 19%
Balance sheet total	€ 971,836 Balance sheet total 2022: € 971,836 First fiscal year in the series	€ 792,715 Balance sheet total 2023: € 792,715 ▼ 18% vs 2022 (€ 971,836) Unchanged	€ 885,432 Balance sheet total 2024: € 885,432 ▲ 12% vs 2023 (€ 792,715) Unchanged	€ 1,069,775 Balance sheet total 2025: € 1,069,775 ▲ 21% vs 2024 (€ 885,432) Unchanged	▲ 21%
Employees (FTE)	1.7 Employees (FTE) 2022: 1.7 First fiscal year in the series	1.4 Employees (FTE) 2023: 1.4 ▼ 0.3 vs 2022 (1.7) Unchanged	1.4 Employees (FTE) 2024: 1.4 Unchanged (1.4) Unchanged	1.4 Employees (FTE) 2025: 1.4 Unchanged (1.4) Unchanged

Key figures of Apotheek Vermylen, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Apotheek Vermylen?

What happened at Apotheek Vermylen in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 3, 2026 New annual accounts for financial year 2025: profit of € 234,765 (▲ 11% vs 2024). Source: NBB ↗
Aug 18, 1980 New establishment in Heist-op-den-Berg. KBO
Aug 18, 1980 Start of the company according to the CBE. KBO

In short

From € 157,018 profit in 2022 to € 234,765 profit in 2025.

Paid € 270,821 in corporate taxes since 2022.

Best year ever: 2025, with € 234,765 profit.

On average € 340,500 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Storms Pharma 99.8%

The stake of Storms Pharma comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Apotheek Vermylen

Behind Apotheek Vermylen are Kathleen Vermylen and Storms Pharma BVBA. The shares are held by Storms Pharma (99.8%).

Directors

According to the 2025 annual accounts

Kathleen Vermylen

Bestuurder

Storms Pharma BVBA

Bestuurder · represented by Valerie Storms

Shareholders

Storms Pharma

99.8%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Leo Kempenaersstraat 7

2223 Heist-op-den-Berg

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Storms Pharma same network

€ 77,174 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0420.633.867

VAT number

BE 0420.633.867

Registered office

Leo Kempenaersstraat 7, 2223 Heist-op-den-Berg

Names & denominations

Apotheek Vermylen

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

18 August 1980

Peppol

Active · Active since 24 Nov 2023

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

Apotheek Vermylen

Financials

What happened to Apotheek Vermylen?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions